thanks gestalt - that's very helpful. clearly you
Post# of 144712
![](/images/icons/icon_smile.gif)
that being the case, when you look at the NASH data that was released at the conference, it is your opinion that this data is good enough to be a catalyst for a partnership with a legitimate player (a Gilead, GSK, PFE, etc.)?
it sure would be great to be down the road in those discussions already. I just have no ability to gague these results, and if they are strong enough to motivate a big player to sign us up.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)